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It is a great honor and privilege for us to introduceAnna S.F. Lok, M.D., as the 68th President ofthe American Association for the Study of Liver
Diseases (AASLD). As two hepatologists who have
worked closely with her for the past 20 years, we can-
not imagine anyone who is more capable or deserving
to lead our great organization. Anna has all the “right
stuff” to make her a successful president of the
AASLD, including fantastic organization and admin-
istrative skills, unparalleled work ethic, and extensive
research, teaching, and mentoring experience that she
unselfishly and skillfully shares with others.
Born in Hong Kong, Anna was the second of 4 sib-
lings with 2 brothers and 1 sister. Her father worked in
a bank and her mother was a homemaker. Not surpris-
ingly, Anna excelled academically at a young age and
had a particular passion and interest for science, which
was not “recommended” for girls of her time. After
completing eleventh grade, she made the bold move to
apply to a boy’s school with a strong reputation for sci-
ence education. Despite being the only girl in a class of
31 boys, she graduated with top honors and was
quickly accepted to the University of Hong Kong
School of Medicine. Following 5 years of intense train-
ing, she graduated as the most outstanding medical
student of the year. She made all of her friends and
family very proud as the first and only physician in her
family.
Anna continued on with her internship and residen-
cy training in Internal Medicine at the Queen Mary
Hospital in Hong Kong. It was during her first rota-
tion as a resident that she fell in love with hepatology.
Influenced by Drs. K.C. Lam and Rudi Schmid (who
was a visiting professor at the time), Anna made the
decision to travel abroad to London to gain further
expertise and knowledge. She was very fortunate to
train under the premier hepatologist of the time, Prof.
Dame Sheila Sherlock, at the Royal Free Hospital in
London from 1982 to 1983. It was at the Royal Free
that Anna began her lifelong quest to become a leader
in hepatology research. Seminal work there included
the first study of thrice-weekly interferon (IFN) for
chronic hepatitis B as well as a randomized trial of ade-
nine arabinoside, an oral antiviral agent, which proved
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to be associated with peripheral neuropathy. From this
experience, Anna developed a keen eye for medication-
induced side effects and the importance of detailed
observation of patients. The years spent at the Royal
Free were highly productive for Anna on the academic
front, with a total of 23 papers and book chapters. But
more important was the invaluable mentorship she
received from Howard Thomas and Dame Sheila,
enrollment into the “Sherlock Liver Family”, and the
lifelong friendships she established with other fellow
trainees, including Patrizia Farci, David Novick, Dirk
van Leeuwen, Deirdre Kelly, James Dooley, and the
late Andy Burroughs.
After returning to Hong Kong in 1983, she rose
through the ranks at the University of Hong Kong
until 1992 when she was promoted to Reader in Medi-
cine (Equivalent to Professor of Medicine in the Unit-
ed States). It was during that time that her passion and
devotion to improve the care of patients with hepatitis
B virus (HBV) blossomed. She established a large bio-
repository and clinical database of HBV patients,
which would later prove to be an invaluable resource
for molecular studies that helped determine the basis
for precore stop codon mutations, HBV genotypes,
and predictors of response to IFN-based therapies.
Following this string of successes at a young age, Anna
turned west to look for new challenges and adventures.
Anna successfully crossed the Pacific to take a post as
an Associate Professor at Tulane University, where she
worked closely with the late Michael Gerber. In the
United States, she also began to train a litany of fel-
lows, including Marc Ghany who went on to the
National Institute of Diabetes and Digestive and Kid-
ney Diseases (NIDDK) as an intramural investigator.
In 1995, she was recruited by the late Keith Henley to
the University of Michigan as one of the few female
Professors of Medicine at that time. As the Chief of
Hepatology, Anna has built a tremendous liver pro-
gram at Michigan starting with a small group of five
hepatologists to now 15. As Chung Owyang, our gas-
trointestinal (GI) division chief, recently said, “Anna
single handedly built the Michigan Hepatology Pro-
gram.” In addition to the current team, she also served
as mentor of Jorge Marrero, now at University of Texas
Southwestern, and Michael Volk at Loma Linda. Fur-
thermore, she has trained countless medical students,
medical residents, and GI fellows. Many international
fellows, including Henry Chan from Hong Kong, have
chosen to come to Ann Arbor to work with Anna
either in the lab, the clinic, or on public health
initiatives.
Anna is world renowned for the volume and quality
of her research work. Over the past 30 years, significant
contributions to the field have included helping to
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FIG. 1. Dr. Lok shown in the middle with her siblings and sister-in-law on a family reunion tour.
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define the clinical stages of HBV infections and deci-
phering the role of viral genotypes/variants on disease
progression. Since 2008, she has been the Chair of the
NIDDK-funded Hepatitis B Research Network.
Although Anna’s first love was HBV, she has also con-
tributed to the field of hepatology in many other areas.
She published the first paper on the successful use of
an all-oral direct-acting antiviral regimen in a different
virus entirely—hepatitis C. She was also the inventor
of the aspartate aminotransferase to platelet ratio index
and Lok Index, some of the first noninvasive methods
to determine the presence of advanced fibrosis and cir-
rhosis. This has benefited innumerable patients, and
its utility can be demonstrated by the fact that the
World Health Organization, the Centers for Disease
Control and Prevention (CDC), and numerous
research groups around the world have adopted them
into their staging algorithms.
As a foreign medical graduate, Anna successfully
secured a Veterans Affairs (VA) Merit Award 1 year
after arriving in the United States and has been con-
tinuously funded by the VA/National Institutes of
Health since. Her accomplishments and awards are
too innumerable to list; more recent ones include:
AASLD Distinguished Service Award (2011), Amer-
ican Liver Foundation Distinguished Scientific
Achievement award (2015), and AGAWilliam Beau-
mont Prize in Gastroenterology (2016). She will be
the recipient of the Canadian Association for the
Study of Liver Gold Medal Award and an Hon.
D.Sc. degree from her alma mater later this year. Her
stature in the world of hepatology is unparalleled. She
has published more than 400 peer-reviewed papers
and 15 chapters in the widely used UpToDate series.
She is co-editor of the Sherlock Hepatology text book
and has an H Index of 96 (Scopus). During the peri-
od of 2002-2012, she was in the top 1% of researchers
cited worldwide. In recognition of her outstanding
research and administrative skills, she has also served
as the Associate Chair for Clinical Research in the
Department of Internal Medicine and, more recently,
was appointed as Assistant Dean for Clinical
Research to oversee the Clinical Trials Transforma-
tion Initiative.
With all of her clinical and scientific contributions
to academic hepatology, what is really remarkable is
Anna’s devotion to the AASLD, which she considers
the premier society in the field of hepatology. Anna’s
service to the AASLD has been immense. She has
been a member of the society since 1988, and in that
time, she has served on innumerable committees,
chaired and moderated countless numbers of sessions
at the Annual Meeting, as well as single-topic confer-
ences. In addition, she co-authored the AASLD Prac-
tice Guidelines for Hepatitis B from 2001 to 2009.
One of the highlights of Anna’s career has been her 5-
year tenure as an associate editor for HEPATOLOGY dur-
ing the tenure of the late Andy Blei.
Anna’s service to hepatology goes well beyond her
investigative work. As a busy clinical hepatologist,
Anna has provided invaluable service to her patients,
many of whom are very grateful for her services. As a
testament of how much her patients and their families
appreciate her care, the Andrews family endowed a
chair and several other patients have established named
research funds in honor of Anna. Anna was among the
first group of faculty inducted into the Department of
Internal Medicine’s Clinical Excellence Society.
Beyond her clinical service, Anna has also been active
in community service through her work in the Asian
Health Foundation and the Asian Pacific American
Medical Student Association, bringing advocacy and
education regarding liver disease to the community at
large. Anna also worked tirelessly with the CDC and
the Hepatitis B Foundation to change the recommen-
dations regarding scope of practice and to eliminate
discrimination against medical/dental students and
health care workers with HBV.
What is less well known is Anna’s unswerving will-
ingness to help colleagues in need of hepatology clini-
cal care advice. Anna gets several e-mails per week
from physicians all over the world asking her ques-
tions regarding diagnostic or therapeutic dilemmas.
What is extraordinary is that whether it is in Australia
or Africa, Anna finds time in her incredibly busy
schedule to answer these e-mails so as to help these
physicians take better care of their patients with liver
disease.
Those of us who are fortunate enough to spend time
with Anna know her incredibly generous nature and
her selfless devotion to her colleagues and mentees.
She is the type of mentor and colleague where you may
send her a manuscript or request thinking that if you
got a response within a few days that would be excel-
lent, even though the norm is 2-3 weeks for someone
with her responsibilities. What you find is that within
hours, the manuscript is back and edited with her
meticulous eye. As mentors ourselves now, we can tell
you that this level of involvement and caring is incredi-
bly inspiring. One mentee remembers “the shock of
getting his first paper back from her, and seeing the sea
of red with very few of his original words or phrases
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remaining.” He now recognizes how valuable it is to
have a detail-oriented and constructively critical men-
tor who notices all mistakes before the paper or grant
is submitted.
This level of dedication is what has made Anna an
exceptional mentor for so many at the University of
Michigan, Tulane, Hong Kong, and beyond. Anna’s
mentoring extends to many who have not directly
worked with her, her adopted children who span the
globe. Kyong-Mi Chang at the University of Pennsyl-
vania has considered Anna an important mentor since
the 1990s. She describes how truly selfless Anna is in
encouraging and guiding so many young people (her
“children” as she calls them who, over the years, gradu-
ate to being her “siblings”). She still remembers when
Anna agreed by email (sight unseen) to meet her, a
“mere GI fellow” at the time, to talk about career
development. As Kyong-Mi says: “She’s like a Mom
who won’t suffer nonsense, but would be there for you
and push you to do your best.” Anna’s mentees also
include nonhepatologists such as Jessica Hwang, an
internist at MD Anderson, who has dedicated her
career to preventing HBV reactivation.
To many of us, Anna is a serious person who is all
about work. For those of us who know her well, Anna is
our own “Tiger Mom.” Anna is single, but she has
many “children” all over the world whom she fosters
and nurtures. She pushes us academically, but is also
there for us at all our games, even if it is something out
of her nature, such as roller derby matches. Anna’s bio-
logical family is dispersed in Canada, Australia, and
Hong Kong, but they are tightly knit. After their moth-
er passed away 2 years ago, Anna set aside a fund for
annual family reunions to bond and to just have fun
together (Fig. 1).
In conclusion, it is apparent that Anna Lok has the
credentials, energy, and skills to lead the AASLD going
forward. Her unwavering passion to improve the care of
patients with liver disease worldwide, coupled with her
administrative, organizational, and academic skills, will
benefit all members of the society. Although she is a
person of high standards, she helps pull others around
her up in an effort to improve things for the greater
good. Congratulations Anna. We are so excited about
your tenure as the new AASLD president and look for-
ward to making great strides under your leadership.
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